Learning Portfolio: Eli Lilly – Diabetes Treatment Update – Diabetes – Insulin and GLP 1

You are invited to a CPD Accredited Eli Lilly Virtual Zoom Meeting

Topic: Diabetes Treatment Update – Diabetes – Insulin and GLP 1                                            

Points to be discussed

  1. Reviews the physiology of GLP-1 and outlines the benefits and evolution of the GLP-1 receptor agonist class, for treatment of Type 2 Diabetes patients.
  2. Introduces the once-weekly GLP-1 receptor agonist dulaglutide, and provides an overview of its efficacy and safety clinical data from the AWARD trial program
  3. Reviews the evolution of cardiovascular outcomes trials for GLP1-RAs and outlines the primary prevention demonstrated by dulaglutide in the REWIND study.

Speaker: Dr Emmanuel Danso  

Date: 28 June 2022

Time 13h30 – 14h30

Once registered you will receive the Zoom link to join the meetings. The zoom link will be resent in a reminder SMS to all registrants only, closer to the date.


Network Management